tiprankstipranks
Advertisement
Advertisement

PYPD Stock Latest News

PolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital
The FlyPolyPid NDA acceptance ‘meets or exceeds’ expectations, says Roth Capital
3d ago
PYPD
PolyPid announces FDA acceptance of, priority review for D-PLEX100
PremiumThe Fly
PolyPid announces FDA acceptance of, priority review for D-PLEX100
4d ago
PYPD
PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market
PremiumCompany Announcements
PolyPid Wins FDA Priority Review for D-PLEX100 NDA, Accelerating Path to Market
4d ago
6K
PYPD
PolyPid price target lowered to $12 from $13 at Craig-Hallum
PremiumThe Fly
PolyPid price target lowered to $12 from $13 at Craig-Hallum
11d ago
PYPD
Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue
PremiumThe Fly
Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue
11d ago
PYPD
PolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential
PremiumTipRanks NewswirePolyPid Locks in a Transformative Deal Worth Over $320 Million, With Additional Major Royalty Potential
12d ago
PYPD
PolyPid Stock (PYPD) Plummets Despite Deal With Azurity to Tackle Surgical Infections
Premium
Market News
PolyPid Stock (PYPD) Plummets Despite Deal With Azurity to Tackle Surgical Infections
12d ago
PYPD
PolyPid Strikes Azurity Commercialization Deal for D-PLEX100 in U.S. and Canada
Premium
Company Announcements
PolyPid Strikes Azurity Commercialization Deal for D-PLEX100 in U.S. and Canada
12d ago
6K
PYPD
PolyPid enters exclusive pact with Azurity Pharmaceuticals for D-PLEX100
PremiumThe Fly
PolyPid enters exclusive pact with Azurity Pharmaceuticals for D-PLEX100
12d ago
PYPD
Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That
PremiumTipRanks Newswire
Surgical Infections Cost Hospitals Billions. One Under-the-Radar Biotech Player Might be About to Change That
19d ago
LLY
NXTC
Lilly’s $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid’s Asset is Hiding in Plain Sight
PremiumTipRanks Newswire
Lilly’s $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid’s Asset is Hiding in Plain Sight
1M ago
LLY
PYPD
PolyPid Sets July 15, 2026 Shareholder Meeting to Vote on Board, Auditor and Equity Grants
PremiumCompany Announcements
PolyPid Sets July 15, 2026 Shareholder Meeting to Vote on Board, Auditor and Equity Grants
2M ago
6K
PYPD
PolyPid completes NDA submission to FDA for D-PLEX100
PremiumThe FlyPolyPid completes NDA submission to FDA for D-PLEX100
2M ago
PYPD
PolyPid Files NDA with FDA for Lead Infection-Prevention Drug D-PLEX100
Premium
Company Announcements
PolyPid Files NDA with FDA for Lead Infection-Prevention Drug D-PLEX100
2M ago
6K
PYPD
PolyPid’s Earnings Call Signals Tightrope to Approval
Premium
Company Announcements
PolyPid’s Earnings Call Signals Tightrope to Approval
2M ago
PYPD
PolyPid Earnings Call: NDA Momentum Amid Cash Strain
PremiumCompany Announcements
PolyPid Earnings Call: NDA Momentum Amid Cash Strain
3M ago
PYPD
PolyPid reports Q1 EPS (35c), consensus (43c)
PremiumThe Fly
PolyPid reports Q1 EPS (35c), consensus (43c)
3M ago
PYPD
PolyPid Advances D-PLEX₁₀₀ Toward FDA Review as Q1 2026 Loss Narrows and Debt Is Retired
PremiumCompany Announcements
PolyPid Advances D-PLEX₁₀₀ Toward FDA Review as Q1 2026 Loss Narrows and Debt Is Retired
3M ago
6K
PYPD
PYPD Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PYPD Upcoming Earnings Report: What to Expect?
3M ago
PYPD
PolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
PremiumCompany AnnouncementsPolyPid Begins FDA NDA Submission for D-PLEX₁₀₀ to Prevent Surgical Infections
4M ago
6K
PYPD
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
Premium
TipRanks Newswire
PolyPid’s Moment Is Here: NDA Submission Begins as a High-Impact Catalyst Stack Takes Shape (NASDAQ: PYPD)
4M ago
APLS
PYPD
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
Premium
TipRanks Newswire
PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention
5M ago
CING
OVID

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >